Hi Folks. Conundrum for you;How do you check facts for Fake News when the algorithms set up by Facebook, Twitter, Google and co base their facts on data which is taken from the wrong article source and not related to the taken down YOU TUBE video below, a brilliant commentary exposing the downright shocking and disgusting journalistic and supposedly factual and honest dealings with the general public and their subscriptions to these social, media giants and of course the media.
The long articles down below show you and give you more understanding about vaccines and add weight to the statement below on legally declining vaccines---vaccines have many other adjuvants. This may not be worth much as in the UK, may override it:-
https://www.legislation.gov.uk/ukpga/1984/22/contents and in the USA 'The Emergency Powers Act'. (full explanation of this act in the Dark Journalist in POST 392 R) Many doctors I know are concerned that they maybe forced to break their Hippocratic Oath and are loath to do so but they could be forced too under this act and merely to lose their job means to not save lives, so they are between a rock and hard place.
THIS LAW
AT THE END HOW TO LEGALLY DECLINE VACCINES.https://www.legislation.gov.uk/ukpga/1984/22/contents and in the USA 'The Emergency Powers Act'. (full explanation of this act in the Dark Journalist in POST 392 R) Many doctors I know are concerned that they maybe forced to break their Hippocratic Oath and are loath to do so but they could be forced too under this act and merely to lose their job means to not save lives, so they are between a rock and hard place.
From Mercola.com
STORY AT-A-GLANCE
·
NewsGuard
recently announced that my site has been classified as fake news because we
have reported the SARS-CoV-2 virus as potentially having been leaked from the
biosafety level 4 laboratory in Wuhan City , China
·
According
to NewsGuard, “There is no evidence that the Wuhan Institute of Virology was
the source of the outbreak, and genomic evidence has found that the virus is 96%
identical at the whole-genome level to a bat coronavirus”
·
NewsGuard’s
position is in direct conflict with published scientific evidence suggesting
this virus was created in a lab and not zoonotically transmitted
·
SARS-CoV-2
appears to be a bat coronavirus modified to integrate spike proteins that
allows the virus to enter human cells by attaching to ACE-2 receptors, as well
as an envelope protein from HIV called GP141, which impairs immune function
·
Many
mainstream media, U.S. U.K. Wuhan
STORY AT-A-GLANCE
·
According
to the CDC, most COVID-19 cases are asymptomatic or mild, including in
children, unless an individual has an underlying chronic health problem
·
With
almost every state government following federal guidelines and either
requesting or ordering residents to quarantine themselves at home — whether
they are healthy or sick — families are facing unprecedented economic losses
·
U.S.
·
Dominated
by the U.K. GlaxoSmithKline , France U.S.
·
At
a White House briefing of the Coronavirus Task Force, Dr. Fauci confirmed that
strict social distancing and quarantine measures are at least partially in
place to prevent populations from developing natural herd immunity
Dr. Anthony Fauci, director of the National Institute for Allergy and
Infectious Diseases (NIAID) told Americans on April 1, 2020 that modeling
reports suggested COVID-19 infections could eventually "kill 100,000 to
240,000 Americans,"1,2,3 which was considerably less
than the worst case 1.7 million mortality figure the U.S. Centers for Disease
Control and Prevention (CDC) talked about on March 13,4 and a fraction of the
doomsday 2.2 million mortality figure projected by a scientist at Imperial
College London.5,6
The next day, Fauci called for an all-state nationwide lockdown7 and CDC officials
instructed Americans to cover their faces with cloth masks if they have to
leave their homes to buy food or seek medical care.8
On April 6, University of Washington modeling experts, who influenced the
setting of current federal and state "social distancing" policies,
lowered U.S. COVID-19 mortality estimates from the worst case 162,000
fatalities they predicted on March 26 to about 82,000 deaths.9,10
Two days later, on April 8, they lowered U.S. U.S.
"If back to normal means acting like there never was a
coronavirus problem, I don't think that is going to happen until we have a
situation where you can completely protect the population.
If you want to get to pre-coronavirus, that might never happen in the
sense of the fact that the threat is there, but I believe with the therapies
that will be coming online and the fact that I feel confident that over a
period of time, we will get a good vaccine, we will never have to get back to
where we are right n
COVID-19 Deaths by the
Numbers
By April 12, 2020 ,
there had been nearly 22,000 COVID-19 related deaths reported in the U.S.
According to the CDC, most cases are asymptomatic or mild, including in
children,14 unless
an individual has an underlying chronic health problem like asthma, obesity,
diabetes, autoimmunity, immune suppression, high blood pressure, chronic
obstructive pulmonary disease (COPD) or heart disease.15,16,17,18
There are large mortality variations among different countries and similar
wide variations in mortality among populations living in different states in
the U.S.19
At least one study published on April 5 has found that air pollution
subjecting individuals to long term exposure to fine matter particulates
greatly increases the risk for death from COVID-19, noting that, "The
majority of the pre-existing conditions that increase the risk of death for
COVID-19 are the same diseases that are affected by long-term exposure to air
pollution."20
A small increase in long-term exposure to PM2.5 [fine particulate matter]
leads to a large increase in COVID-19 death rate, with the magnitude of
increase 20 times that observed for PM2.5 and all-cause mortality. The study
results underscore the importance of continuing to enforce existing air
pollution regulations to protect human health both during and after the
COVID-19 crisis.
A March 30 report in The Lancet estimated the overall case fatality ratio
in China has been 1.38%, but is substantially higher in those over 60 years
old.21 Recent
published data from the CDC also confirms that mortality in the U.S. is much
higher among senior citizens over age 65, rising to 10% to 27% for those over
age 85.22
The CDC continues to state that individuals at higher risk for serious
illness from COVID-19 infection are those over age 65 and "people of all
ages with underlying medical conditions, particularly if not well
controlled."23
Advertisement
US COVID-19 Mortality Statistics:
Science or Assumptions?
On March 24, the director of Division of Vital Statistics, National
Center
"The underlying cause [of death] depends upon what and where
conditions are reported on the death certificate. However the rules for coding
and selection of the underlying cause of death are expected to result in
COVID-19 being the underlying cause more often than not."
CDC officials make it clear that on cases where the death certificate
indicates uncertainty about the cause of death, there will likely be no follow
up and the death will be listed as COVID-19:
"If a death certificate reports terms such as 'probable COVID-19'
or 'likely COVID-19,' these terms would be assigned the new ICD code [UO7.1
COVID-19]. It is not likely that NCHS will follow up on these cases."
Finally, answering the question, "Should COVID-19 be reported on the
death certificate only with a confirmed test?" the CDC's memo emphasizes
that lab confirmation of COVID-19 is unnecessary to list the cause of death as
COVID-19 on the death certificate:
"COVID-19 should be reported on the death certificate for all
decedents where the disease caused or is assumed to have
caused or contributed to death."
In an April 9 NBC Today Show interview, Dr. Fauci was asked whether some
deaths are being falsely counted as COVID-19 deaths when they are really due to
other causes. He replied:24
"There's absolutely no evidence that that's the case at all. I
think it falls under the category of something that's been unfortunate —
conspiracy theories that we hear about every time we have a crisis of any sort.
There's always this popping up of conspiracy theories. I think the
deaths that we're seeing are coronavirus deaths and the other deaths are not
being counted as coronavirus deaths … I think there's more of a chance of
missing some that are really coronavirus deaths not being counted."
Economic and Social Meltdown
Continues
More than two months after the World Health Organization (WHO) declared
the outbreak of COVID-19 in China as a "Public Health Emergency of
International Concern,"25 which
was followed the next day by the CDC's January 31 declaration of a national
Public Health Emergency in the U.S.,26 it appears that the government's pandemic
planning efforts spanning four decades failed to prepare federal and state
health agencies to respond quickly,27,28,29,30,31 despite
federal legislation32 that
ensured substantial annual congressional appropriations to the U.S. Department
of Health and Human Services (DHHS) since 2006 for pandemic planning.33,34
Right now, COVID-19 testing kits are slowly rolling into the states but in
limited quantities,35,36 and
health care workers are continuing to report critical shortages of personal
protective equipment (PPE) and medical supplies.37,38,39
With almost every state government following federal guidelines and either
requesting or ordering residents to quarantine themselves at home — whether
they are healthy or sick — families are facing unprecedented economic losses.40
On April 3, the U.S. Bureau of Labor Statistics (BLS) reported huge
declines in employment in the leisure and hospitality industries — mainly in
food and beverage — but also in health care, social assistance, professional
and business services, retail trade, and construction.41
Unemployment in the U.S. U.S.
Lower income families without savings and dependent upon hourly wages and
part-time work in service professions are hit especially hard.42 Understaffed social
service support systems are struggling to cope with significant increases in
depression, spousal and child abuse, and calls to suicide hotlines.43,44,45
However, some scientists,46,47 doctors48 and politicians49 want quarantines to
stay in effect beyond April 31, even though the managing director of the
International Monetary Fund Kristalina Georgieva warned on April 9 that the
economic fallout of shutdowns is approaching that of the Great Depression.50
We are still faced with extraordinary uncertainty about the depth and
duration of this crisis. It is already clear, however, that global growth will
turn sharply negative in 2020, as you can see in our World Economic Outlook. In
fact, we anticipate the worst economic fallout since the Great Depression.
Bill Gates Calls for 10-Week
Nationwide Shutdown
In an OpEd in The Washington Post published March 31, Microsoft founder
and philanthropist social reformer Bill Gates called for a nationwide federally
enforced quarantine for all states that would last "10 weeks or
more:"
"Because people can travel freely across state lines, so can the
virus. The country's leaders need to be clear: Shutdown anywhere means shutdown
everywhere. Until the case numbers start to go down across America
Several days earlier in a TED interview, Gates talked about how the strict
social distancing and quarantine measures in place in the U.S. U.S.
He also stated there will be a need for people to have
"certificates" that prove they have either recovered from the
infection or have been vaccinated once a vaccine is produced. He said:53
"Now we don't want to have a lot of recovered people, you know.
To be clear, we're trying through the shutdown in the United
States
Eventually, what we'll have to have is certificates of who is a
recovered person, who's a vaccinated person, because you don't want people
moving around the world where you'll have some countries that won't have it
under control, sadly. You don't want to completely block off the ability for
people to go there and come back and move around."
Fauci Agrees: COVID-19
Natural Herd Immunity Not Wanted
At a White House briefing of the Coronavirus Task Force held April 6, Dr.
Fauci confirmed that strict social distancing and quarantine measures are at
least partially in place to prevent populations from developing natural herd
immunity. He said:54
"One issue that's going to be important and it has to do with
somewhat of a comparison, for example, with influenza. We go through multiple
cycles of influenza [and] there's always a degree of background immunity in a
population.
That will ultimately happen [with COVID-19] if we get a situation
where we get back to normal. Now, I hope we don't have so many people infected
that we actually have that herd immunity, but I think it would have to be
different than it is right now."
In an April 9 interview on National Public Radio (NPR), Bill Gates
returned to the message that some "social distancing" measures have
to stay in place "until we get a vaccine that almost everybody's
had." He said:
"What I'm saying, what Dr. [Anthony] Fauci is saying, what some
other experts are saying, there's a great deal of consistency. We're not sure
yet which activities should be resumed, because until we get a vaccine that
almost everybody's had, the risk of a rebound will be there …
As we follow the numbers into May and see if we can get them down to a
very low level, then in parallel, this debate about which things have benefits
to society and can be formatted so the infection risk is very low, which things
should we resume? I do think manufacturing, construction, a lot of things we'll
do, but large public gatherings may have to wait until we have that
vaccine."
Governments Make Fast-Tracked
COVID-19 Vaccines Main Priority
Immediately after the January 30 WHO declaration that a novel coronavirus
outbreak in China posed a "public health emergency of international
concern," press releases were issued by the Gates Foundation55 and World Health
Organization (WHO)56 informing
the world that experimental coronavirus vaccines already in development would
be put on a fast track to licensure for global use.
On March 9, WHO released its COVID-19 R&D roadmap that, according to
BioWorld, had been endorsed by "400 experts" and included funding
from the European Commission (37.5 million euros), German government (10
million euros) and an additional 46 million euros from the U.K. government,
with 20 million euros going directly to the Coalition for Epidemic Preparedness
(CEPI) for vaccine development.
CEPI committed $100 million to speed up licensure of COVID-19 vaccines but
said it was trying to raise $2 billion more to speed vaccines to market.57
The WHO's R&D plan stated there was an "urgent need" to fill
in scientific knowledge gaps about the "basic biology" of COVID-19
infection and clinical evolution of COVID-19 and its epidemiology, as well as
the need to develop appropriate animal models for research because some
previous SARS and MERS vaccine studies in animals showed enhanced respiratory
disease can occur in vaccinated animals after exposure to the live virus.
The WHO roadmap stated, "Evaluating the potential for enhanced
disease in humans is critical before [vaccines] can be assessed through
larger-scale studies."58 By
mid-March and early April, the WHO, National Institutes of Health,59 universities,60 and global
pharmaceutical corporations61 had
announced development of more than 50 experimental COVID-19 vaccines.62,63
Using vitamin and supplement therapies or currently licensed prescription
drugs64,65,66,67,68,69 has
taken a back seat to an aggressive push to keep restrictive "social
distancing" measures in place until fast tracked experimental vaccines are
licensed.70,71,72
Maintaining that the only solution to dealing with the new coronavirus is
universal use of a new vaccine,73,74 this
single solution approach guarantees even bigger profits in the exploding global
vaccine market that has doubled over the past decade from $20 billion in 201075 to $42 billion in
2018.76 Dominated
by the U.K.'s GlaxoSmithKline, France's Sanofi and U.S. drug giants Merck and
Pfizer, the vaccine market is projected to double again by 2026 to over $93
billion.77
There are already reports from Wall Street predicting big gains in biotech
stocks based on multiple companies developing COVID-19 vaccines and new drugs.78
One company, Moderna, which is partnering with the National Institute of
Allergy and Infectious Diseases (NIAID) headed by Dr. Fauci, has seen a 78%
increase in its stock price since it announced in February that its
experimental messenger RNA vaccine was ready for clinical trials.79 The company's CEO
has become a new billionaire overnight.80
Big Pharma Getting More Money
to Deliver COVID-19 Vaccines
Responding to the call by public health officials to lockdown the U.S. March 27, 2020 that will cost
American taxpayers over $2 trillion. The federal legislation includes $27
billion for development of COVID-19 vaccines, drug therapies and purchase of
pandemic medical supplies.
The legislation did not include a cap placed on how much money drug
companies can charge and profits they can make on the COVID-19 vaccines and
drug therapies they develop with the use of money from the government. Already,
there are questions being raised about just how far the price gouging will go
when those COVID-19 drugs and vaccines are licensed by the FDA and recommended
by the CDC.81
On March 30, the DHHS Assistant Secretary of Preparedness and Response
announced that the government is taking steps to "speed the development
and manufacturing of vaccines to prevent COVID-19."82
The same day, Johnson & Johnson issued a press release stating that the
Biomedical Advanced Research and Development Authority (BARDA) had awarded
J&J's Janssen Pharmaceutical Companies $1 billion to establish new U.S.
vaccine manufacturing capabilities and additional production capacity outside
the U.S and produce a global supply of more than 1 billion doses of the
COVID-19 vaccine using AdVac® and PER.C6® technologies.83
J&J plans to initiate human clinical studies in September 2020 and
deliver the first batches of vaccine for emergency use authorization in early
2021.84
BARDA was created by Congress in 2006 under the Pandemic and All Hazards
Preparedness Act,85 legislation
that has given billions of dollars to DHHS since then to develop
"bioterrorism" and pandemic influenza vaccines.86 That federal
legislation also removed all civil liability from pharmaceutical companies for
injuries and deaths caused by vaccines and drugs manufactured in response to
declared public health emergencies, such as pandemics.87
According to a March 30 Reuters report, Moderna, Inc. "also signed a
deal with the Biomedical Advanced Research and Development Authority (BARDA),
part of the DHHS. The arrangements are part of the federal government's effort
to encourage drugmakers to be able to produce massive amounts of COVID-19
vaccines even before any are proven to work."88
Earlier in March, the NIAID headed by Dr. Fauci issued a press release on
March 16 announcing that a Phase1 human clinical trial conducted by Kaiser
Permanente Washington Health Research Institute in Seattle has begun to
evaluate an experimental mRNA vaccine for COVID-19 (mRNA-1273) co-developed by
NIAID scientists and scientists at Moderna, Inc, based in Cambridge,
Massachusetts.
The Coalition for Epidemic Preparedness (CEPI) helped fund the
manufacturing of the vaccine for the Phase 1 clinical trial.89
Moderna and NIAID are conducting human trials of the experimental
mRNA-1273 COVID-19 vaccine without first conducting animal trials, which has
always been an important part of the vaccine licensing process.90 On March 30, Moderna
stated that its COVID-19 vaccine might be ready for emergency use in some
people, including healthcare workers, by the fall of 2020:91
"The Company further reported that while a commercially-available
vaccine is not likely to be available for at least 12-18 months, it is possible
that under emergency use, a vaccine could be available to some people, possibly
including healthcare professionals, in the fall of 2020.
Any emergency use would be subject to authorization by the appropriate
regulatory agencies, based on the emergence of clinical data for mRNA-1273 that
would support use of the vaccine prior to licensure."
An April 3 Philadelphia Inquirer article trumpeting that "Coronavirus
has created a new golden age for vaccines and Philly is at the heart of
it,"92 pointed
out at least part of the heavy financial investments the U.S. government has
made in vaccine development through BARDA since 2006:
"When the original BioShield funding ran out, Congress began a
series of annual appropriations totaling about $1.5 billion a year to fund
BARDA vaccine development efforts and to build up the emergency medical
stockpile. A special $5 billion was appropriated for the multinational Ebola
virus fight in 2015.
The [March 2020] CARES Act has multiplied those resources, splitting
$27 billion between rebuilding the depleted medical stockpile and BARDA vaccine
funding — on top of $6 billion appropriated for those purposes in the first
anti-coronavirus bills last winter."
Experimental COVID-19
Vaccines Using Eight Different Platforms
Coronaviruses are a group of diverse, single-stranded, enveloped RNA
viruses that cause a wide range of respiratory, gastrointestinal and neurologic
illnesses with varying severity in animals and humans.
Most coronaviruses, including those causing the common cold, are not
associated with significant mortality, with the exception of Severe Acute
Respiratory Syndrome (SARS-CoV), which emerged in China in 2002, and the
coronavirus causing Middle East Respiratory Syndrome (MERS-CoV), which was
identified in Jordan and Saudi Arabia in 2012.93 COVID-19 is referred to in the medical
literature as severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) or
COVID-19.94
Drug companies and government agencies racing to be the first to license a
COVID-19 vaccine, are using different technology platforms to create
experimental vaccines: inactivated virus; attenuated virus; protein subunit;
virus-like particle, DNA, RNA and non-replicating vector.95 Traditional vaccines
contain attenuated or inactivated viruses and bacteria or proteins, as well as
adjuvants, such as aluminum, to stimulate an immune response that produces
artificial immunity.
For example, older viral vaccines for smallpox and measles vaccine contain
live attenuated viruses; injectable influenza vaccines contain inactivated
viruses; the recombinant hepatitis B virus vaccine is a protein subunit
vaccine, while the newer human papillomavirus (HPV) virus vaccine contains
virus like particles.
For the past two decades, researchers have been experimenting with new
technology platforms, notably ones that introduce foreign DNA and RNA into
cells of the body, to develop experimental vaccines for SARS, MERS, HIV and
other diseases but, so far, none have been proven effective and safe for
humans.96
DNA and mRNA Vaccines: Flying
Blind Into Uncharted Territory
Gene-based vaccines encode a viral protein from a pathogen (like COVID-19)
in human DNA or mRNA. DNA vaccines deliver pieces of DNA into human cells to
stimulate the immune system to create antibodies specific to pathogenic
proteins without causing disease.
DNA vaccines require no culture or fermentation for production and no
refrigeration after production because they are made in a lab using synthetic
processes, and can be produced in large quantities for less money than
traditional vaccines.97
Messenger RNA (mRNA) vaccines inject human cells with mRNA, usually within
lipid nanoparticles, to stimulate cells in the body to become manufacturers of
viral proteins.98,99
In March 2020, a virologist at Imperial College London told Chemistry
World that one advantage of using mRNA technology to make vaccines for humans
is that, "Rather than generating proteins in a manufacturing plant and
purifying them, you are getting the muscle to do the job and make the protein
itself."100
Like DNA vaccines, mRNA vaccines can be produced in the lab using faster
and less expensive process than traditional vaccines. RNA vaccines can be
delivered with syringes, nasal spray or needle-free into the skin (patches).
Although neither DNA or mRNA vaccines have been tested in large-scale
clinical trials, an April 3 article in Chemical and Engineering News highlights
the breakneck speed at which COVID-19 vaccines "are moving new
technologies from the computer and into the clinic at an unprecedented
rate." What should be separate pre-licensure phases for proving safety and
effectiveness — preclinical animal models, clinical testing, and manufacturing
— are now "happening all at once."101
·
"It's
like building an airplane when you are flying," said Inovio
Pharmaceuticals CEO Joseph Kim.
·
"They
have been described as the vaccines of the future," says
Dan Barouch, director of the Center for Virology and Vaccine Research at Beth
Israel Deaconess
Medical Center
·
"It
will be the first time that they will be tested in so many people," says
Wim Tiest, a former vaccine developer at GlaxoSmithKline now heading up a
COVID-19 program at the Belgian mRNA vaccine company eTheRNA Immunotherapies.
But will spending lots of money to cut corners and speed up licensing of
COVID-19 vaccines using experimental DNA and mRNA technology — or other types
of new technology — end up putting millions of people at risk for vaccine
failures and reactions leading to chronic illness?
There are nagging questions about DNA102 and mRNA103 vaccine platforms and they are not
trivial. According to a 2011 article in Harvard College Global Health Review,
DNA vaccine safety concerns include such potential side effects as:104
·
"chronic inflammation because the vaccine
continually stimulates the immune system to produce antibodies"
·
"possible integration of plasmid DNA into
the body's host genome, resulting in mutations, problems with DNA replication,
triggering of autoimmune responses, and activation of cancer-causing
genes"
According to researchers at University
of Pennsylvania Duke
University
·
Local and systemic inflammation
·
Stimulation of auto-reactive antibodies
·
Induction of a potent type 1 inteferon
responses, which have been associated with inflammation and potential
autoimmunity
·
Presence of extracellular RNA, which may
contribute to edema and pathogenic thrombus formation (blood clots)
Top COVID-19 Vaccine
Candidates Being Tested
Following is a selection of companies identified by MarketWatch that are
among those leading the race to be the first to get a COVID-19 vaccine licensed
for global use:106,107
Inovio Pharmaceuticals, Inc. (US) — Inovio's
COVID-19 vaccine (INO-4800) is a DNA vaccine that will be tested in 30
clinical trials in the
Inovio received a $5M grant from the Gates Foundation to test a delivery
device for INO-4800 and a $9M grant from CEPI to accelerate development of
the COVID-19 vaccine.
In partnership with Florida-based Ology Bioservices, Inc, Inovio secured
an $11.9-million contract with the Department of Defense for upcoming clinical
trials and potential manufacturing of the vaccine for military personnel in
the future.109 Describing
Inovio's DNA vaccine, Precision Vaccinations states:110
"This one-of-a-kind
platform delivers optimized DNA into cells, where it is translated into
proteins that activate an individual's immune system to generate a robust
targeted T cell and antibody response.
CELLECTRA uses a brief
electrical pulse to open small pores in the cell reversibly to allow the
plasmids to enter. Once inside the cell, the plasmids begin replicating,
thereby strengthening the body's own natural response mechanisms."
|
Johnson & Johnson, Inc. (
Phase 1 clinical trials of the
J&J vaccine are scheduled for September 2020 and the company is planning
to have investigational doses of vaccine available for "emergency
use" by early 2021.
|
Moderna, Inc. (
|
Pfizer, Inc. (U.S.) and
BioNTech (Germany) — In a joint venture with BioNTech, Pfizer
will develop and distribute an mRNA vaccine produced by BioNTech (BNT-162),
expected to enter clinical testing by the end of April 2020 in Germany and
the U.S. BioNTech is also testing the vaccine in collaboration with Shanghai
Fosun Pharmaceutical Group in China.
|
Dynavax Technologies Corp. (U.S.) and Clover Biopharmaceuticals
(China) — China's Clover Biopharmaceuticals has developed a
protein-based subunit coronavirus vaccine candidate (COVID-19 S-Trimer) and
Dynavax, a California based biotech company, is providing technical expertise
and the company's proprietary toll-like receptor 9 (TLR9) agonist adjuvant,
CpG 1018 for use in Clover's COVID-19 vaccine.
Dynavax's CpG 1018 is a synthetic
oligonucleotide adjuvant that is used in recombinant hepatitis B vaccine
Heplisav-B. Dynavax is also collaborating with
|
GlaxoSmithKline plc
(U.K.) and Clover Biopharmaceuticals, Inc. (China) — GSK has an
AS03 vaccine adjuvant system platform that it is making available to Australia's
University of Queensland and to Clover Biopharmaceuticals, Inc., a Chinese
biotechnology company that will use GSK's AS03 adjuvant in combination with a
COVID-19 S-Trimer vaccine. S-Trimer is a trimeric SARS-CoV-2 spike
(S)-protein subunit vaccine candidate.
|
Sanofi SA (France) — Sanofi
is working with BARDA to use its recombinant DNA platform to test a
preclinical vaccine candidate for SARS to manufacture a COVID-19 vaccine. In
2017, Sanofi acquired Protein Sciences, which had been developing a SARS
vaccine.
|
Novavax, Inc. (
According to Novavax, Matrix-M is a sanponin-based adjuvant that
contains purified saponin fractions mixed with synthetic cholesterol and a
phospholipid to form stable particles that stimulate a strong immune response
and "enhancing antigen presentation in the local lymph nodes."113
Novavax has received $4 million
from CEPI to develop a COVID-19 vaccine and Emergent Biosolutions, Inc. has
indicated it would support contract development and manufacturing of the
vaccine. The company plans to start Phase 1 clinical studies by June.
|
CureVac AG (
|
Vaxart, Inc. (
|
Although
As of
|
Copernicus Atmosphere
Monitoring Service, ECMWF Total column ozone
field (in Dobson Units) from CAMS on 29 March 2020 showing values below
250 DU over large parts of the Arctic .
Scientists who were tracking the hole at Copernicus' Atmospheric Monitoring
Service (CAMS) made the announcement late last week, noting the
"rather unusual" hole was caused not by human activity but a particularly strong Arctic
polar vortex, CAMS said.
Thus, despite what you may be thinking, it's recovery most
likely can't be tracked to the reduction in pollution due
to the coronavirus pandemic.
MORE ON THE DANGERS OF VACCINES 392 U. Remember aduvants are Bio-accumulative and build up like toxins and hard to detoxify if at all. So with continual annual jabs and shots------?
BE WELL
GEOFF
ADDENDUM
This is worryingly applicable to the UK and this particular bunch of 'health advisers' we a have a Eugenics government adviser to the Prime Minister, Mr Cummings----can we be sure who these others are?. Mr Cummings is not a medical man so what is he even doing there?
https://youtu.be/O1bAzSviLYc
EMF METER
Read this if you have an EMF Meter it may not be 'strong' enough to give you an accurate reading and you maybe exposed to far more EMF's than indicated.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.